Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q1 2020 · 10-Q
Revenue$178.46M$178.46M+7.6% vs Q1 2019 Net Income$18.48M$18.48M−11.0% vs Q1 2019 EPS Diluted$1.56$1.56−8.2% vs Q1 2019 Gross Profit$135,240,000+8.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flow$26,735,000−18.3% Free Cash Flowderived$26,441,000−6.5% Margins · derivedGross margin75.8%+0.3 pt vs Q1 2019
Operating margin13.2%−1.7 pt vs Q1 2019
Net margin10.4%−2.2 pt vs Q1 2019
ended Mar 31, 2020 · filed May 6, 2020 · 36 d after period end